Our Portfolio

PharmaTher manages the following assets in its portfolio:

1. 3D Printing: Personalized medicines for regulated peptides and compounded pharmaceuticals;
2. Ketamine: FDA-approved in the U.S. and ketamine microneedle patch development; and
3. Cepharanthine: Patented enteric-coated oral cepharanthine for infectious diseases (Hantavirus).